US$ 21.52
lipid pnl c ldl and Lipoprotein Basics | Clinical Guidance Emerging risks of lipid-lowering therapy
Description
Role of Trimethylamine N-Oxide in Heart Failure

The arrival of Lp(a)-lowering agents may transform Lp(a) from a risk marker into a direct therapeutic target, but outcome trials are needed before routine pharmacologic Lp(a)-lowering can be recommended

HSF-1 activity is also coupled to the nutrient-sensing insulin/IGF-1 signaling to regulate normal development of the germline [68]

Dib I, Khalil A, Chouaib R, El-Makhour Y, Noureddine H

N Engl J Med 373(7):621-31, 2015
